Manuel I. Hermosilla
Pharma Companies Argue That Lower Drug Prices Would Mean Fewer Breakthrough Drugs. Is That True?
Probably not, a new study suggests—as long as the price decreases are modest.
Researchers: David Dranove, Craig Garthwaite and Manuel I. Hermosilla
September 2, 2020